A Single Center Experience of Super-Responders Among Severe Asthma Patients Receiving Treatment with Mepolizumab [0.03%]
莫普利单抗治疗重度哮喘患者的超级反应者的单一中心经验
Emel Atayık,Gökhan Aytekin
Emel Atayık
Objective: Anecdotal reports among clinicians treating severe asthma patients with novel add-on treatments such as mepolizumab suggest that a fraction of these patients may experience a much more dramatic benefit from the...
The Knowledge and Attitude about New Generation Tobacco Products among Physicians [0.03%]
医务人员对新型烟草产品知识和态度调查
Pınar Bostan,Aslı Görek Dilektaşlı
Pınar Bostan
Objective: Health hazards of e-cigarettes including "e-cigarette or vaping product use-associated lung injury" are better understood today. Just as e-cigarettes, heated tobacco products release toxic emissions. We aimed t...
Should Pneumothorax Developing During the Recovery Period After COVID-19 in Patients with Previously Healthy Lungs be Considered a Primary Spontaneous Pneumothorax or a Secondary Spontaneous Pneumothorax? [0.03%]
COVID-19康复期继发的自发性气胸是原发性的还是继发性的？
Selçuk Köse
Selçuk Köse
Objective: It is still unknown how to call the pneumothorax that develops during the recovery period after coronavirus disease 2019. Patients who developed pneumothorax during the recovery period after coronavirus disease...
Coronavirus Disease 2019 Pneumonia Scoring System Comparison and Risk Factors [0.03%]
新型冠状病毒肺炎评分系统对比及危险因素分析
Kerem Ensarioğlu,Ayşe Kevser Erdöl,Bahar Kurt et al.
Kerem Ensarioğlu et al.
Objective: Coronavirus disease 2019 is a disease caused by severe acute respiratory syndrome coronavirus 2, a novel type of coronavi- rus, which causes pneumonia in some hosts. No specific scoring method exists for mortal...
Mahmut Kaya,Gökcen Ömeroglu Şimşek,Eyüp Sabri Ucan et al.
Mahmut Kaya et al.
Objective: To evaluate the patients who were treated for intraocular tuberculosis retrospectively and present our findings and share our experience. Mater...
The Therapeutic Significance of Mesenchymal Stem Cells in COVID-19 Acute Pulmonary Respiratory Disease [0.03%]
间充质干细胞在新冠肺炎急性肺呼吸窘迫综合症中的治疗意义
Derya Dilek Kançağı,Ercüment Ovalı
Derya Dilek Kançağı
The coronavirus disease 2019 pandemic caused by severe acute respiratory syndrome-related coronavirus-2 continues its effects around the world with its new variants. Coronavirus disease 2019 infection may continue with a post-coronavirus di...
Changes in the Number of Newly Diagnosed Lung Cancer Patients Before and During the COVID-19 Pandemic: A Single-Center Experience [0.03%]
新冠疫情前后肺癌新发患者数变化——单中心经验分享
Şule Gül,Mehmet Atilla Uysal,Atilla Çifter et al.
Şule Gül et al.
Objective: The coronavirus disease-2019 pandemic has affected the entire health system and patients other than coronavirus-infected patients. Hospital admissions of cancer patients decreased during the closure periods due...
The Use of High-Flow Nasal Oxygen Therapy in the Management of Severe Acute Exacerbation of Chronic Obstructive Pulmonary Disease: A Feasibility Study [0.03%]
高流量鼻导管吸氧治疗重症慢性阻塞性肺疾病急性加重的可行性研究
Pervin Hancı,Serpil Öcal,Esat Kıvanç Kaya et al.
Pervin Hancı et al.
Objective: This study investigated the efficacy of high-flow nasal oxygen therapy in patients with severe acute exacerbation of chronic obstructive pulmonary disease admitted to the intensive care unit. ...
Coexistence of Multiple Pulmonary Sclerosing Pneumocytoma and Scleroderma-Rheumatoid Arthritis Overlap Syndrome: A Case Report [0.03%]
多发肺硬化性肺瘤合并系统性硬皮病-类风湿关节炎重叠综合征病例报告
Hülya Abalı,Fatma Tokgöz Akyıl,Seda Tural Önür et al.
Hülya Abalı et al.
Pulmonary sclerosing pneumocytoma is a rare, low-grade pulmonary tumor observed as unilateral or bilateral multiple nodules at a rate of 4%-5%. Among the autoimmune connective tissue disorders, those most commonly associated with lung malig...